ChartRow logo
Data provided bySource: Twelve Data
MDGL
$421.99-0.46%
as of close, Nov 17, 2026
☾ AH $421.99 -0.46%
Share this page

Madrigal Pharmaceuticals Inc. trailing returns

Madrigal Pharmaceuticals Inc.'s 10-year return is +38.2% a year (CAGR) (+2434.5% cumulative). How Madrigal Pharmaceuticals Inc. (MDGL) has performed over the last day, week, month and year, over 5 and 10 years, and since inception, through November 17, 2026 — price return and dividends side by side, with the worst drop inside each window.

Trailing returns by period#

Data provided bySource: Twelve Data

To 2026-11-17. Price return + dividends = total return. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.

PeriodPriceDivsTotalWorst drop
Cumulative
1 day-0.5%+0.0%-0.5%—
5 days-2.5%+0.0%-2.5%-2.5%Nov 17
1 month-6.2%+0.0%-6.2%-15.2%Nov 3
YTD-27.5%+0.0%-27.5%-33.3%Nov 3
Per year (CAGR)
1 year-23.7%+0.0%-23.7% CAGR-34.3%Nov 2026
5 years+37.2%+0.0%+37.2% CAGR+385.3% total-61.4%Oct 2023
10 years+38.2%+0.0%+38.2% CAGR25.3x total-82.2%Jan 2022
Since 2007+1.4%+0.0%+1.4% CAGR+32.6% total-98.4%Feb 2016

Growth of MDGL#

Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.

  • 5 years+37.2%/year · +385.3%
  • 10 years+38.2%/year · +2434.5%
  • Since inception (2007)+1.4%/year · +32.6%

Methodology#

Trailing returns measure from the closest close about N years before the latest close (2026-11-17). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in MDGL's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.

FAQ#

What is Madrigal Pharmaceuticals Inc.'s 10-year return?
Over the last 10 years, Madrigal Pharmaceuticals Inc. (MDGL) returned about +38.2% a year annualized (+2434.5% cumulative total return).
What is Madrigal Pharmaceuticals Inc.'s return since inception?
Since 2007, Madrigal Pharmaceuticals Inc. (MDGL) has compounded at about +1.4% a year — +32.6% in total.

More on Madrigal Pharmaceuticals Inc.